🧠 Smart money is quietly buying these undervalued gemsGet the list

Salesforce.com adapts its software for pandemic vaccine distribution

Published 2020-09-30, 06:17 p/m
Updated 2020-09-30, 06:18 p/m
© Reuters. People pass by the Salesforce Tower and Salesforce.com offices in New York

© Reuters. People pass by the Salesforce Tower and Salesforce.com offices in New York

By Stephen Nellis

(Reuters) - Salesforce.com (NYSE:CRM) on Wednesday said it has adapted some of its business software to help healthcare organizations and government entities distribute vaccines for the novel coronavirus once they become available.

The San Francisco-based company said the offering, called Work.com for Vaccines, will help cities, states and health-care groups track vaccine inventory levels, create online appointment portals and track how patients fare after being vaccinated.

"All these vaccines have various levels of quality and efficacy. We all know that they're not all the same," Salesforce.com Chief Executive Marc Benioff told Reuters in an interview. "And so technology will be really critical in separating the wheat from the chaff in the vaccine."

Multiple companies and nations around the world are racing to develop a vaccine to provide some degree of immunity to the novel coronavirus, which causes the disease COVID-19. The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, on Tuesday said she was optimistic the industry will be able to make vaccine widely available next year.

Salesforce.com's efforts build on tools rolled out in May aimed at modifying the company's business software to help governments make re-opening decisions based on public health data and carry out contact tracing and other tasks related to the pandemic.

In a press announcement, Salesforce said pricing will be "based upon the unique requirements of each public agency or private healthcare organization."

"We get the government the price they need," Benioff said. "We know a lot of people are under pressure, and we're going to do whatever we can to make sure that they get the technology at the right price that that's appropriate for them."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

The timeline for a vaccine was a major focus of the U.S. presidential debate on Tuesday. Benioff said the company plans to work with "red states and blue states" and has previously worked with both California and Texas.

© Reuters. People pass by the Salesforce Tower and Salesforce.com offices in New York

"Salesforce is not a Democrat or Republican. Salesforce is an American," he said.

CRM: A Bull or Bear Market Play?

Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if CRM is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.

Unlock ProPicks AI now

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.